日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysis

饮酒与乳腺癌发病率和预后的关系:系统评价和荟萃分析

Arecco, Luca; Cacilhas, Pedro M; Bobato Lara Gismondi, Camila; Bruzzone, Marco; Gentile, Gabriella; Gerosa, Riccardo; Blondeaux, Eva; Agostinetto, Elisa; Dauccia, Chiara; Lobo-Martins, Soraia; Grochot, Rafael; Saini, Kamal S; Azim, Hatem A Jr; Debiasi, Marcio; De Caluwé, Alex; Buisseret, Laurence; Del Mastro, Lucia; Lambertini, Matteo; de Azambuja, Evandro

Unlocking the therapeutic potential of immuno-radiotherapy: insights from preclinical and clinical research

释放免疫放射疗法的治疗潜力:来自临床前和临床研究的启示

Cogels, M M; de Caluwé, A; Buisseret, L; Penninckx, S

Immuno-radiotherapy enhances tumor control and induces abscopal responses in a humanized mouse model

免疫放射疗法可增强人源化小鼠模型中的肿瘤控制并诱导远隔效应

Cogels, Morgane M; Serra, Matteo; Duvillier, Hugues; Garaud, Soizic; Verset, Laurine; Venet, David; Iliadi, Chrysanthi; de Bakker, Tycho; Buisseret, Laurence; Rouas, Redouane; Sotiriou, Christos; Rothé, Françoise; de Caluwé, Alex; Van Gestel, Dirk; Penninckx, Sébastien

Fully Automated Stain Quantification Framework for IHC Whole Slide Images in Breast Cancer.

乳腺癌IHC全切片图像全自动染色定量框架。

Yin Tuo, Lifrange Frédéric, Denis Zoë, de Caluwé Alex, Buisseret Laurence, Catteau Xavier, Legros Clara, Reynaert Nick, Dhont Jennifer

Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study

帕博西尼联合内分泌疗法会降低早期乳腺癌患者的适应性抗肿瘤免疫:NeoRHEA II期研究

Papagiannis, Andreas; Majjaj, Samira; Duhoux, Francois P; Agostinetto, Elisa; Stanciu, Alexandra M; Vanhulst, Thila; Buisseret, Laurence; Larsimont, Denis; Veys, Isabelle; Paesmans, Marianne; Hammer, Tatiana Besse; Awada, Ahmad; Ameye, Lieveke; Rothe, Francoise; Madriles, Francesc; Cash, Timothy P; Salgado, Roberto; Willard-Gallo, Karen; Sotiriou, Christos; Vuylsteke, Peter; Neven, Patrick; Ignatiadis, Michail

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

持续补充功能失调的 CD8 T 细胞轴与晚期乳腺癌化疗免疫疗法的疗效相关

Metoikidou Christina, Karnaukhov Vadim, Boeckx Bram, Timperi Eleonora, Bonté Pierre-Emmanuel, Wang Ling, Espenel Marion, Albaud Benoit, Loirat Delphine, Wang Xiaoxiao, Sotiriou Christos, Aftimos Philippe, Punie Kevin, Wildiers Hans, Labroska Viktorija, Wang Ming-Wei, Waterfall Joshua J, Piccart-Gebhart Martine, Mora Thierry, Walczak Aleksandra, Lantz Olivier, Buisseret Laurence, Lambrechts Diether, Amigorena Sebastian, Romano Emanuela

Personalized ctDNA detection and genomic profiling in the NeoRHEA Study

NeoRHEA研究中的个性化ctDNA检测和基因组分析

Stanciu, Alexandra; Agostinetto, Elisa; Papagiannis, Andreas; Pipinikas, Christodoulos; Chevalier, Amber; Campbell, Nathan; Brandão, Mariana; Ameye, Lieveke; Paesmans, Marianne; Besse, Tatiana; Rothe, Francoise; Buisseret, Laurence; Taylor, Donatienne; Neven, Patrick; Sotiriou, Christos; Duhoux, Francois P; Vuylsteke, Peter; Ignatiadis, Michail

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00

IBCSG 22-00 试验中免疫抑制性 JNK 通路在 TNBC 亚型肿瘤微环境中的作用

Joaquin Garcia, Andrea; Semba, Takashi; Rediti, Mattia; McGrail, Daniel J; Xie, Xuemei; Wang, Xiaoping; Rampa, Dileep R; Venet, David; Buisseret, Laurence; Majjaj, Samira; Kammler, Roswitha; Colleoni, Marco; Loi, Sherene; Viale, Giuseppe; Regan, Meredith M; Rothé, Françoise; Sotiriou, Christos; Ueno, Naoto T

Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications

空间转录组学揭示三阴性乳腺癌中存在显著的异质性,具有潜在的临床意义

Xiaoxiao Wang #, David Venet #, Frédéric Lifrange, Denis Larsimont, Mattia Rediti, Linnea Stenbeck, Floriane Dupont, Ghizlane Rouas, Andrea Joaquin Garcia, Ligia Craciun, Laurence Buisseret, Michail Ignatiadis, Marcela Carausu, Nayanika Bhalla, Yuvarani Masarapu, Eva Gracia Villacampa, Lovisa Franzé

The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab

免疫治疗生物标志物的漫长而曲折之路:对接受派姆单抗治疗的三阴性乳腺癌患者样本的回顾性分析

L Buisseret, Y Bareche, D Venet, E Girard, A Gombos, P Emonts, S Majjaj, G Rouas, M Serra, V Debien, E Agostinetto, S Garaud, K Willard-Gallo, D Larsimont, J Stagg, F Rothé, C Sotiriou